Clinical Trials Directory

Trials / Completed

CompletedNCT01944852

Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD.

Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental Peritoneal Dialysis Therapy: the DIDo Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
117 (actual)
Sponsor
Pr Eric Goffin · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The DIDo study is an open-label, randomised, multicentre study with 2 parallel groups in incident CAPD patients aged of 65 at minimum : * One group in which patients will receive 2 bags of icodextrin/day and 1 bag of glucose * One group in which patients will receive 1 bag of icodextrin/day and 2 bags of glucose.

Detailed description

The DiDo study evaluates efficacy and safety of a Double Icodextrin Dose in elderly incident CAPD patients on incremental Peritoneal Dialysis therapy. The objective is to demonstrate the superiority and safety of using 2, as compared to 1, icodextrin bags / day, in a cohort of elderly incident continuous ambulatory peritoneal dialysis (CAPD) patients using incremental peritoneal dialysis (PD) (3 bags / day), with the aim of prolonging the period of time for which incremental PD can be used. This is a phase IV open-label, randomised, multicentre study with 2 parallel groups, which will take place in up to 30 hospital out-patient clinics un Europe. It is planned to include 160 patients on the run-in period in order to obtain 100 randomised patients and 90 patients evaluable at the primary endpoint (45 in each group). The duration of patient recruitment is estimated at 1 year but this may be extended until all 160 patients are recruited. There are 2 periods: a run-in period of 2 months and a treatment period of 18 months.

Conditions

Interventions

TypeNameDescription
DRUGIcodextrin

Timeline

Start date
2013-03-01
Primary completion
2020-02-28
Completion
2020-02-28
First posted
2013-09-18
Last updated
2020-11-10

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01944852. Inclusion in this directory is not an endorsement.